Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis

Annals of Neurology

Volumn 53, Issue 2, 2003, Pages 189-197

  Tejada Simon, Maria V ^a   Zang, Ying C Q ^a   Hong, Jian ^a   Rivera, Victor M ^a   Zhang, Jingwu Z ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COMPLEMENTARY DNA; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; RNA; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS PROTEIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROLYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; VIRUS INFECTION; VIRUS REACTIVATION;

ADULT; ANTIBODIES, VIRAL; AUTOANTIGENS; CELL LINE; CROSS REACTIONS; CYTOKINES; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; ROSEOLOVIRUS INFECTIONS; T-LYMPHOCYTES;

EID: 0037309220     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10425     Document Type: Article

References (49)

1. Johnson RT. The virology of demyelinating diseases. Neurology 1994;36(suppl):S54-S60.
2. Hunter SF, Hafler DA. Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology 2000;55:164-165.
3. Wandinger K-P, Jabs W, Siekhaus A, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000;55:178-184.
4. Kennedy PGE, Steiner J. On the possible viral etiology of multiple sclerosis. Q J Med 1994;87:523-528.
5. Dalgleish AG. Viruses and multiple sclerosis. Acta Neurol Scand 1997;95:8-15.
6. Monteyne P, Bureau J-F, Brahic M. Viruses and multiple sclerosis. Curr Opin Neurol 1998;11:287-291.
7. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
8. Hafler D. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J Clin Invest 1999;104:527-529.
9. Steinman L, Oldstone MBA. More mayhem from molecular mimics. Antibodies against human herpesvirus-6 have been found in patients with multiple sclerosis. Could this be another sighting in the hunt for the viral trigger of the disease? Nat Med 1997;3:1321-1322.
10. Oldstone MBA. Molecular mimicry as a mechanism for the cause and as a probe uncovering ellologic agent(s) of autoimmune disease. Curr Topics Microbiol Immunol 1989;145:127-138.
11. Oldstone MBA. Molecular mimicry and immune mediated disease. FASEB J 1998;12:1255-1265.
12. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-187.
13. Ben-Nun A, Cohen IR. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 1982;129:303-308.
14. Zamvil SS, Nelson P, Trotter J, et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985;317:355-358.
15. Ota K, Matsui M, Milford EL. T cell recognition of an immunodominant MBP epitope in multiple sclerosis. Nature 1990;346:183-187.
16. Martin R, Howell ND, Jaraquemada D, et al. A MBP peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 1991;173:19-24.
17. Zhang J, Markovic-Plese S, Lacet B, et al. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-984.
18. Tejada-Simon MV, Zang YCQ, Yang D, et al. Aberrant T cells responses to myelin antigens during exacerbation in patients with multiple sclerosis. Int Immunol 2000;12:1641-1650.
19. Chou YK, Bourdette DN, Offner H, et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992;38:105-113.
20. Allegretta M, Nicklas JA, Sriram S, et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721.
21. Wucherpfennig KW, Sette A, Southwood S, et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-290.
22. Hemmer B, Fleckenstein B, Vergelli M, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997;185:1651-1659.
23. Kozovska M, Zang YCQ, Aebischer I, et al. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur J Immunol 1998;28:1894-1901.
24. Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev 1997;10:521-567.
25. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
26. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-7444.
27. Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993;56:917-919.
28. Wilborn F, Schmidt CA, Brinkmann V, et al. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994;49:213-214.
29. Soldan SS, Berti R, Salem N, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased igM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997;3:1394-1397.
30. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-280.
31. Luppi M, Barozzi P, Maiorana S, et al. Human herpesvirus infection in normal human brain tissue. J Infect Diseases 1994;169:943-944.
32. Liedtke W, Malessa R, Faustmann P, et al. Human herpesvirus-6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1:253-258.
33. Tejada-Simon MV, Zang YC, Hong J, et al. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002;76:6147-6154.
34. Enbom M, Wang FZ, Fredrikson S, et al. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999;6:545-549.
35. Goldberg SH, Albright AV, Lisak RP, Gonzalez-Scarano F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol 1999;5:134-139.
36. Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997;95:280-283.
37. Mayne M, Krishnan J, Metz L, et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol 1998;44:391-394.
38. Merelli E, Bedin R, Sola P, et al. Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 1997;244:450-454.
39. Rotola A, Caselli E, Cassai E, et al. Novel human herpesviruses and multiple sclerosis. J Neurovirol 2000;6:S88-S91.
40. Taus C, Pucci E, Cartechini E, et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 2000;101:224-228.
41. Zhang J, Medaer R, Stinissen P, et al. MHC restricted clonotypic depletion of human myelin basic protein by T cell vaccination. Science 1993;261:1451-1454.
42. Wucherpfennig KW, Ota K, Endo N, et al. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 1990;248:1016-1019.
43. Zang YCQ, Kozovska M, Aebischer I, et al. Restricted TCR Vα gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Intern Immunol 1998;10:991-998.
44. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975;94:441-448.
45. Valli A, Sette A, Kappos L, et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 1993;91:616-628.
46. Lehmann PV, Forsthuber T, Miller A, et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
47. Zang YC, Yang D, Hong J, et al. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology 2000;55:397-404.
48. Rudick RA, Ransohoff RM, Lee JC, et al. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 1998;50:1294-1300.
49. Richert ND, Zierak MC, Bash CN, et al. MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b. Mult Scler 2000;6:86-90.